Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/11 17:00 | 4/6/11 | GENZ | Health | BioPrd | Biological Products, (No Diag | Sanofi-Aventis | I0 | T | P.m | 1,240,049 | 17.84 | 0 | 69,520 | 38 | 253,559 | I | |||||||||||||||
9/14/09 12:02 | 9/10/09 | GENZ | Health | BioPrd | Biological Products, (No Diag | Dzau Victor J | MA | D | P | 55 | 55.00 | 0 | 1 | 25 | 5 | I | |||||||||||||||
4/24/09 10:08 | 4/23/09 | GENZ | Health | BioPrd | Biological Products, (No Diag | Meeker David P | MA | O | ExecVP,T | P | 104 | 51.95 | 0 | 2 | 56 | 6 | D | ||||||||||||||
3/6/09 10:58 | 3/4/09 | GENZ | Health | BioPrd | Biological Products, (No Diag | Bamforth Mark R | MA | O | Sr.VP,Co | P | 38 | 54.54 | 0 | 1 | 18 | 5 | B | ||||||||||||||
12/12/08 13:25 | 12/10/08 | GENZ | Health | BioPrd | Biological Products, (No Diag | Dzau Victor J | MA | D | P | 100 | 64.80 | 0 | 2 | New | 2 | I | |||||||||||||||
3/19/07 12:40 | 3/12/07 | GENZ | Health | BioPrd | Biological Products, (No Diag | Moscicki Richard A | MA | O | SVP | P | 579 | 60.32 | 0 | 10 | 35 | 37 | D | ||||||||||||||
6/16/06 12:36 | 5/11/06 | GENZ | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | O | EVP | P.a | 169 | 56.47 | 0 | 3 | 50 | 9 | B | ||||||||||||||
5/15/06 11:58 | 5/11/06 | GENZ | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | O | EVP | P | 169 | 56.47 | 0 | 3 | 50 | 9 | B |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |